Scandion Oncology: Sights set on the immuno-oncology arena - Redeye

Redeye comments on Scandion announcing the conclusion of its immuno-oncology collaboration with Alligator Biosciences. With positive results in hand, we believe Scandion is now ready to explore combinations of SCO-101 and immuno-oncology drugs more broadly.

Länk till analysen i sin helhet: https://www.redeye.se/research/820120/scandion-oncology-sights-set-on-the-immuno-oncology-arena?utm_source=finwire&utm_medium=RSS